(Q73023870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J Guay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J P Falgueyret

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Ducret

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M D Percival

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J A Mancini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

6311-6318

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Design of potent and selective human cathepsin K inhibitors that span the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Role of the occluding loop in cathepsin B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Autocatalytic activation of human cathepsin K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

A protein-folding reaction under kinetic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Surface activation of pro-cathepsin L

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Potent slow-binding inhibition of cathepsin B by its propeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

The inhibition of cathepsin S by its propeptide--specificity and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

The alpha1/2 helical backbone of the prodomains defines the intrinsic inhibitory specificity in the cathepsin L-like cysteine protease subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Expression, maturation, and rhodamine-based fluorescence assay of human cathepsin K expressed in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

pH-induced Conformational Transitions of the Propeptide of Human Cathepsin L

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

The propeptide of Fasciola hepatica cathepsin L is a potent and selective inhibitor of the mature enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Delineating functionally important regions and residues in the cathepsin B propeptide for inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Crystal structure of wild-type human procathepsin K

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

Human cathepsins F and W: A new subgroup of cathepsins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01730.X

10.1046/J.1432-1327.2000.01730.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11012686%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference